Table 3.
Description of outcome variables for the study population with maternal chemical measurements and follow-up examination (n=101).
| N | Median (25-75 pct) | |
|---|---|---|
| Hormones | ||
| Total testosterone (nmol/L) | 101 | 20.1 (17.5-24.4) |
| SHBG (nmol/L) | 101 | 33.6 (27.7-41.4) |
| Free Testosterone (pmol/L) | 101 | 452 (383-514) |
| Estradiol (pmol/L) | 101 | 93 (81-111) |
| LH (IU/L) | 101 | 4.0 (3.0-5.2) |
| TT/LH ratio | 101 | 5.4 (3.8-6.8) |
| INSL3 (mg/L) | 101 | 1.3 (1.1-1.7) |
| FSH (IU/L) | 101 | 3.0 (2.1-5.2) |
| Inhibin B (pg/ml) | 101 | 186 (143-239) |
| Inhibin B/FSH ratio | 101 | 69 (32-107) |
| IGF-1 (ng/ml) | 101 | 278 (249-326) |
| IGFBP3 (ng/ml) | 101 | 4397 (4067-4879) |
| Time of blood sampling (hh:mm) | 101 | 9:25 (8:50-10:29) |
| Semen parameters | ||
| Semen volume (ml) | 99 | 3.0 (2.0-4.1) |
| Sperm concentration (million/ml) | 99 | 52 (22-81) |
| Total sperm count (million) | 99 | 131 (56-284) |
| Progressively motile spermatozoa (%) | 99 | 60 (47-70) |
| Morphologically normal spermatozoa (%) | 99 | 8 (5-11) |
| Ejaculation abstinence (h) | 99 | 62 (48-85) |
| Time until motility analysis (min) | 92 | 46 (40-51) |
| Anogenital distance | ||
| AGDAS (cm) | 88 | 5.9 (5.0-7.1) |
| AGDAP (cm) | 88 | 12.7 (12.0-13.5) |